Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 68382-257

9 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 68382-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxybutynin Chloride Extended-release Tablet (F54e4d4e 91be 4e10 A446 57ed5e1843a1 01)

Oxybutynin Chloride Extended-release Tablet (F54e4d4e 91be 4e10 A446 57ed5e1843a1 01)
Chemical structure of oxybutynin hydrochloride, showing the arrangement of atoms including phenyl, cyclohexyl, and ester groups, along with the hydrochloride component.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets (F54e4d4e 91be 4e10 A446 57ed5e1843a1 02)

Oxybutynin Chloride Extended Release Tablets (F54e4d4e 91be 4e10 A446 57ed5e1843a1 02)
A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours between oxybutynin chloride extended-release tablets 10 mg once daily and oxybutynin 5 mg three times daily. The x-axis represents time in hours, and the y-axis shows mean plasma concentration. The graph includes error bars indicating variability at each time point.*
FDA Label Image

Oxybutynin Chloride Extended Release Tablets (F54e4d4e 91be 4e10 A446 57ed5e1843a1 03)

Oxybutynin Chloride Extended Release Tablets (F54e4d4e 91be 4e10 A446 57ed5e1843a1 03)
A line graph depicting mean R-oxybutynin plasma concentration (ng/mL) over time (hours) from 0 to 24 hours. Data points oscillate around 0.5 to slightly above 0.5 ng/mL, with error bars indicating variability at each time point. The concentration peaks around 5 hours and decreases slightly by 24 hours.*
FDA Label Image

Study 1 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 04)

Study 1 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 04)
A horizontal error bar chart comparing oxybutynin chloride extended-release tablets to placebo, showing data points and ranges on a numerical scale from -40 to 40.*
FDA Label Image

Study 2 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 05)

Study 2 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 05)
A horizontal error bar plot depicting data points for oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40, with the data points centered around -20, each with horizontal error bars indicating variability or confidence intervals.*
FDA Label Image

Study 3 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 06)

Study 3 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 06)
A horizontal error bar plot comparing two items: "Oxybutynin chloride extended-release tablets" and "oxybutynin." The chart has a horizontal axis ranging from -40 to 40, with bars extending symmetrically around points for each item, reflecting variability or confidence intervals.*
FDA Label Image

5 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 07)

5 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 07)
Label for Oxybutynin Chloride Extended-Release Tablets, USP, 5 mg, film-coated extended-release oral tablets. The label states 'Swallow tablets whole. Do not chew, divide or crush tablets.' It includes storage instructions, manufacturer Zydus Lifesciences Ltd., and distributor Zydus Pharmaceuticals (USA) Inc. The package quantity is 100 tablets, prescription only.*
FDA Label Image

10 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 08)

10 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 08)
Label for oxybutynin extended-release tablets, USP 10 mg by Zydus Pharmaceuticals USA Inc. The film-coated tablets are presented in a bottle of 100 count, marked Rx only. The label includes directions to swallow tablets whole and cautions against cutting, dividing, or crushing.*
FDA Label Image

15 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 09)

15 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 09)
Label for oxybutynin chloride extended-release tablets, USP, 15 mg strength. The film-coated tablets are extended-release form, supplied in a package of 100 tablets. Manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions, dosage form, and warnings to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.